205 related articles for article (PubMed ID: 15112472)
1. [Effect and tolerability of sequential administration of estradiol valerate and medroxyprogesterone acetate on menopausal symptoms, hormonal profile and biochemical markers in climacteric women].
Radowicki S; Skórzewska K; Borakowska B; Wierzba W; Michalewski K
Ginekol Pol; 2004 Jan; 75(1):39-46. PubMed ID: 15112472
[TBL] [Abstract][Full Text] [Related]
2. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
Alwers R; Urdinola J; Onatra W; Sánchez F; Posso H
Maturitas; 1999 May; 32(1):41-50. PubMed ID: 10423715
[TBL] [Abstract][Full Text] [Related]
3. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.
Heikkinen J; Kyllönen E; Kurttila-Matero E; Wilén-Rosenqvist G; Lankinen KS; Rita H; Väänänen HK
Maturitas; 1997 Mar; 26(2):139-49. PubMed ID: 9089564
[TBL] [Abstract][Full Text] [Related]
4. The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.
Egarter C; Geurts P; Boschitsch E; Speiser P; Huber J
Acta Obstet Gynecol Scand; 1996 Apr; 75(4):386-93. PubMed ID: 8638462
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effect of two hormonal preparations in postmenopausal women.
Bissonnette F; Lussier-Cacan S; Fugère P; Bérubé S
Maturitas; 1997 Jul; 27(3):275-84. PubMed ID: 9288700
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
Saure A; Planellas J; Poulsen HK; Jaszczak P
Maturitas; 2000 Feb; 34(2):133-42. PubMed ID: 10714908
[TBL] [Abstract][Full Text] [Related]
7. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Marslew U; Overgaard K; Riis BJ; Christiansen C
Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
[TBL] [Abstract][Full Text] [Related]
8. Long-term sequential treatment with combined estradiol valerate and cyproterone acetate in early postmenopause.
Polatti F; Capuzzo E; Viazzo F; Colleoni R; Abbiati I; Nappi RE
Acta Obstet Gynecol Scand; 1999 Jan; 78(1):49-53. PubMed ID: 9926892
[TBL] [Abstract][Full Text] [Related]
9. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
Chandeying V; Sangthawan M
J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
[TBL] [Abstract][Full Text] [Related]
10. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
11. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
[TBL] [Abstract][Full Text] [Related]
12. Randomized cross-over study of a 21-day versus a 28-day hormone replacement therapy (HRT).
McCarthy T; Dramusic V; Carter R; Costales A; Ratnam SS
Maturitas; 1995 Jun; 22(1):13-23. PubMed ID: 7666812
[TBL] [Abstract][Full Text] [Related]
13. Effect of hormone replacement therapy and calcitonin on bone mass in postmenopausal women.
Meschia M; Brincat M; Barbacini P; Maini MC; Marri R; Crosignani PG
Eur J Obstet Gynecol Reprod Biol; 1992 Oct; 47(1):53-7. PubMed ID: 1330761
[TBL] [Abstract][Full Text] [Related]
14. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.
Dören M; Reuther G; Minne HW; Schneider HP
Am J Obstet Gynecol; 1995 Nov; 173(5):1446-51. PubMed ID: 7503183
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women.
Yang TS; Tsan SH; Chen CR; Chang SP; Yuan CC
Zhonghua Yi Xue Za Zhi (Taipei); 1999 May; 62(5):308-15. PubMed ID: 10389286
[TBL] [Abstract][Full Text] [Related]
16. [Effects of estrogen supplementation on psychological variables in climacteric women].
Gramegna G; Blümel JE; Jara S; Schiattino I; Lolas F
Rev Med Chil; 1996 Oct; 124(10):1240-4. PubMed ID: 9239913
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with transcutaneous estradiol and oral medroxyprogesterone acetate.
Pedersen OD; Jensen HK
Acta Obstet Gynecol Scand; 1992 Dec; 71(8):593-8. PubMed ID: 1336917
[TBL] [Abstract][Full Text] [Related]
18. [Effect of estradiol valerate and chlormadinone acetate in hormone replacement therapy in postmenopause on Kupperman index, body weight, blood pressure, lipids, enzymes and electrolytes].
Göretzlehner G; Nikschick S; Zimmermann T
Zentralbl Gynakol; 1996; 118(7):420-5. PubMed ID: 8766107
[TBL] [Abstract][Full Text] [Related]
19. [Hormone substitution treatment of the menopause].
González-Merlo J; Castelo-Branco C; Celades M
Rev Med Univ Navarra; 1992; 37(3):143-51. PubMed ID: 1336213
[No Abstract] [Full Text] [Related]
20. Endocrine effects in Asian postmenopausal women treated with SH D 461 M and Prempak-C.
Goh HH; McCarthy TG; Dramusic V; Costales A; Junge W; Ratnam SS
Maturitas; 1994 Dec; 20(2-3):165-73. PubMed ID: 7715469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
